Health Care - The Market Herald

" Sona Nanotech (CSE:SONA) shares plunge on FDA ruling

Skittish investors are abandoning shares in Sona Nanotech (SONA) today, after its COVID-19 antigen test application was downgraded by the US FDA.

Telehealth provider CloudMD (DOC) is set to acquire digital healthcare platform iMD Health Global in a cash-share deal valued at C$10 million.

Microbix Biosystems (MBX) has received Australian Therapeutic Goods Administration (TGA) approval for its COVID-19 quality assessment products.

Medical technology company, DIAGNOS (ADK) has received an interest-free loan of up to C$2 million from the government of Quebec.

Medical technologists Therma Bright (THRM) leapt up 17 per cent today, after identifying series of polypeptides for the detection of COVID-19.

Champignon Brands (SHRM) is set to offer esketamine as a treatment for adults with major depressive disorder (MDD) at its clinic in Ontario.

Sona Nanotech (SONA) has revealed promising clinical evaluation study results for its rapid detection COVID-19 antigen test.

Biotechnology company, Ceapro (CZO) has successfully achieved the first milestone in developing an inhalable COVID-19 therapeutic.

SQI Diagnostics (SQD) has appointed Robert L Chioini to the role of Chief Executive Officer.

Microbix Biosystems (MBX) has unveiled its second quarter report, which shows a seven per cent decrease in revenue against 2019’s same quarter.